Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News RebrAIn expands capabilities with second FDA 510(k) clearance for OptimMRI software RebrAIn, a France-based precision neurosurgery platform, has achieved a significant milestone with its second FDA 510(k) clearance for… byPallavi MadhirajuAugust 30, 2024